|
Volumn 4, Issue 2, 1998, Pages 73-91
|
Management of HIV-1 infection in children: Special considerations
a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALCOHOL;
ASPARAGINASE;
AZATHIOPRINE;
CLARITHROMYCIN;
DELAVIRDINE;
DIDANOSINE;
ESTROGEN;
FLUCONAZOLE;
FUROSEMIDE;
GANCICLOVIR;
INDINAVIR;
KETOCONAZOLE;
LAMIVUDINE;
METHYLDOPA;
NELFINAVIR;
NEVIRAPINE;
PENTAMIDINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
SULINDAC;
TETRACYCLINE;
THIAZIDE DIURETIC AGENT;
UNINDEXED DRUG;
VALPROIC ACID;
ZALCITABINE;
ZIDOVUDINE;
ADOLESCENT;
ANEMIA;
BLOOD TOXICITY;
CONFUSION;
DIARRHEA;
DRUG ERUPTION;
FATIGUE;
FEVER;
GRANULOCYTOPENIA;
HAIR LOSS;
HEADACHE;
HEMATURIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERPIGMENTATION;
HYPERURICEMIA;
INFANT;
INTRAVENOUS DRUG ADMINISTRATION;
LACTIC ACIDOSIS;
LETHARGY;
LIVER DYSFUNCTION;
MOUTH ULCER;
MUSCLE INJURY;
MYALGIA;
NAUSEA;
NEPHROLITHIASIS;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PANCREATITIS;
PARESTHESIA;
PEDIATRICS;
PERIPHERAL NEUROPATHY;
PHOTOSENSITIZATION;
RETINA DISEASE;
REVIEW;
VOMITING;
|
EID: 0031755434
PISSN: 11738790
EISSN: None
Source Type: Journal
DOI: 10.2165/00115677-199804020-00002 Document Type: Article |
Times cited : (2)
|
References (6)
|